Literature DB >> 9749725

N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain.

A Kinnunen1, T Kinnunen, M Kaksonen, R Nolo, P Panula, H Rauvala.   

Abstract

Heparin-Binding Growth-Associated Molecule (HB-GAM)/pleiotrophin is an 18 kDa extracellular matrix- and cell-surface-associated protein shown to enhance neurite outgrowth of perinatal forebrain neurones in vitro. The heparan sulphate proteoglycan N-syndecan (Raulo et al., 1994) has been isolated as a receptor/coreceptor for the HB-GAM. We have investigated, whether HB-GAM and N-syndecan could have a similar role in neurite outgrowth and axon guidance in early axonal tracts of brain. In the present study N-syndecan was found to be spatiotemporally associated with the developing axonal tracts already on embryonic day 9 in rat, as revealed by coexpression with class III beta-tubulin, which is one of the earliest neuronal markers (Easter et al., 1993; Brittis et al., 1995). Later, N-syndecan and HB-GAM were detected in the first afferent serotonergic projections arising from the pontine raphe nuclei. The expression pattern of HB-GAM peaked in the developing rhombencephalon at embryonic stage (E) 13-14. At the same time, N-syndecan was expressed in the developing raphe neurones growing neurites towards the diencephalon along HB-GAM immunoreactive pathways. When rhombencephalic neurones were cultured on decreasing concentrations of substrate-bound HB-GAM, E13 neurones showed a significantly better neurite outgrowth response than E11, E16 or E18 neurones. The neurite outgrowth of raphe neurones in vitro was inhibited by adding soluble heparin or N-syndecan into the culture medium, whereas addition of chondroitin sulphate had no effect. In a simple pathway assay, E13 raphe neurones selectively preferred attaching and growing neurites on pathways containing HB-GAM as compared with regions containing either laminin or fibronectin alone. Our results suggest that HB-GAM may function as a developmentally regulated cue for rhombencephalic neurones that possess N-syndecan on their cell membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749725     DOI: 10.1046/j.1460-9568.1998.00082.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Authors:  Sara E Gombash; Jack W Lipton; Timothy J Collier; Lalitha Madhavan; Kathy Steece-Collier; Allyson Cole-Strauss; Brian T Terpstra; Anne L Spieles-Engemann; Brian F Daley; Susan L Wohlgenant; Valerie B Thompson; Fredric P Manfredsson; Ronald J Mandel; Caryl E Sortwell
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Midkine promotes perineural invasion in human pancreatic cancer.

Authors:  Jun Yao; Wen-Yao Li; Shuo-Guo Li; Xiao-Shan Feng; She-Gan Gao
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Pleiotrophin expression during odontogenesis.

Authors:  Heidi Erlandsen; Jennifer E Ames; Amena Tamkenath; Olga Mamaeva; Katherine Stidham; Mary E Wilson; Pablo Perez-Pinera; Thomas F Deuel; Mary Macdougall
Journal:  J Histochem Cytochem       Date:  2012-02-29       Impact factor: 2.479

5.  N-syndecan deficiency impairs neural migration in brain.

Authors:  Anni Hienola; Sarka Tumova; Evgeny Kulesskiy; Heikki Rauvala
Journal:  J Cell Biol       Date:  2006-08-14       Impact factor: 10.539

Review 6.  ECM receptors in neuronal structure, synaptic plasticity, and behavior.

Authors:  Meghan E Kerrisk; Lorenzo A Cingolani; Anthony J Koleske
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

Review 7.  Pleiotrophin and peripheral nerve injury.

Authors:  Li Jin; Chen Jianghai; Liu Juan; Kang Hao
Journal:  Neurosurg Rev       Date:  2009-05-08       Impact factor: 3.042

8.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

9.  Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis.

Authors:  Jun Yao; Qingyong Ma; Liancai Wang; Min Zhang
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 10.  The role of heparan sulphate in development: the ectodermal story.

Authors:  Vivien Jane Coulson-Thomas
Journal:  Int J Exp Pathol       Date:  2016-07-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.